Proteomic biomarkers for diagnosis in acute myocardial infarction

References

• Alaiti MA, Maroo A, Edel TB. (2009). Troponin levels after cardiac electrophysiology procedures: review of the literature. Pacing ClinElectrophysiol 32:800–10.
   PubMed Web of Science ®Google Scholar
• Alhadi HA, Fox KAA. (2004). Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein. QJM 97:187–98.
   PubMed Web of Science ®Google Scholar
• Amritsar J, Stiharu I, Packirisamy M. (2006).Bioenzymatic detection of troponin C using micro-opto-electro-mechanical systems. J Biomed Opt 11:021010.
   Web of Science ®Google Scholar
• Antman E, Bassand J-P Klein, W, Ohman M, Lopez Sendon JL, Ryden L, Simoons M, Tendera M. (2000). Myocardial infarction redefined – a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/American College of Cardiology Committee. J Am CollCardiol36:959–69.
   Google Scholar
• Apple FS, Jaffe AS, Newby LK, Kaplan AL, Tuttle RH, McNulty SE, Ohman EM, Storrow AB, Gibler WB, Garvey JL,. (2001). Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study response. Circulation 104:e125–6.
   Web of Science ®Google Scholar
• Apple FS, Smith SW, Pearce LA and others Murakami MM. (2009).Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome. ClinChem55:93–100.
   Google Scholar
• Apple FS, Wu AH, Jaffe AS.(2002). European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 144:981–6.
   PubMed Web of Science ®Google Scholar
• Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O and others. (2005). Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. ClinChem 51:810–24.
   Google Scholar
• Aukrust P, Muller F, Ueland T, Berget T, Aaser E, Brunsvig A, Solum NO, Forfang K, Froland SS, Gullestad L. (1999). Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 100:614–20.
   PubMed Web of Science ®Google Scholar
• Azzazy H.M.E. and Christenson R.H. Cardiac markers of acute coronary syndromes: is there a case for point-of-care testing? Clin. Biochem. 35 (2002), pp. 13–27. Article | PDF (217 K) | View Record in Scopus | Cited By in Scopus (25)
   PubMed Web of Science ®Google Scholar
• Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, Simoons ML, Hamm CW, on behalf of the CI. (2003). Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108:1440–5.
   PubMed Web of Science ®Google Scholar
• Body R, Griffith CA, Keevil B, McDowell G, Carley S, Ferguson J, Mackway-Jones K. (2009). Choline for diagnosis and prognostication of acute coronary syndromes in the Emergency Department. ClinicaChimicaActa 404:89–94.
   PubMed Web of Science ®Google Scholar
• Braunwald E. (2008). Biomarkers in heart failure. N Engl J Med 358:2148–59.
   PubMed Web of Science ®Google Scholar
• Brennan M-L Penn, MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJand others. (2003). Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349:1595–604.
   PubMed Web of Science ®Google Scholar
• Burlina A, Zaninotto M, Secchiero S, Rubin D, Accorsi F. (1994). Troponin T as a marker of ischemic myocardial injury. ClinBiochem 27:113–21.
   PubMed Web of Science ®Google Scholar
• Casals G, Filella X, Bedini JL. (2007). Evaluation of a new ultrasensitive assay for cardiac troponin I. ClinBiochem 40:1406–13.
   PubMed Web of Science ®Google Scholar
• Chan D, Ng L. (2010). Biomarkers in acute myocardial infarction. BMC Med 8:34.
   PubMed Web of Science ®Google Scholar
• Chapelle J-P, Allaf, ME, Larbuisson R, Limet R, Lamy M, Heusghem C. (1986). The value of serum CK-MB and myoglobin measurements for assessing perioperative myocardial infarction after cardiac surgery. Scand J Clin Lab Invest 46:519–26.
   PubMed Web of Science ®Google Scholar
• Chapelle JP. (1999). Cardiac troponin I and troponin T: recent players in the field of myocardial markers. ClinChem Lab Med 37:11–20.
   Google Scholar
• Cheng M-L, Chen, C-M, Gu P-W, Ho, H-Y, Chiu DT-Y. (2008). Elevated levels of myeloperoxidase, white blood cell count and 3-chlorotyrosine in Taiwanese patients with acute myocardial infarction. ClinBiochem 41:554–60.
   PubMed Web of Science ®Google Scholar
• Christenson RH, Apple FS, Morgan DL, Alonsozana GL, Mascotti K, Olson M, McCormack RT, Wians FH Jr, Keffer JH, Duh S-H. (1998). Cardiac troponin I measurement with the ACCESS immunoassay system: analytical and clinical performance characteristics. ClinChem 44:52–60.
   Google Scholar
• Christenson RH, Cervelli DR, Bauer RS, Gordon M. (2004). StratusCS cardiac troponin I method: performance characteristics including imprecision at low concentrations. ClinBiochem 37:679–83.
   PubMed Web of Science ®Google Scholar
• Christenson RH, Fitzgerald RL, Ochs L, Rozenberg M, Frankel WL, Herold DA, Show Hong D, Alonsozana GL, Jacobs E. (1997). Characteristics of a 20-minute whole blood rapid assay for cardiac troponin T. ClinBiochem 30:27–33.
   PubMed Web of Science ®Google Scholar
• Chu WW, Dieter RS, Stone CK. (2002a). Evolving clinical applications of cardiac markers: a review of the literature. WMJ 101:49–55.
   PubMedGoogle Scholar
• Chu WW, Dieter RS, Stone CK. (2002b).A review of clinically relevant cardiac biochemical markers.WMJ 101:40–8.
   Google Scholar
• Collinson PO. (1998). Troponin T or troponin I or CK-MB (or none?). Eur Heart J 19 (Suppl. N):N16–24.
   PubMed Web of Science ®Google Scholar
• Danne O, Lueders C, Storm C, Frei U, Möckel M. (2007). Whole blood choline and plasma choline in acute coronary syndromes: Prognostic and pathophysiological implications. ClinChimActa 383:103–9.
   PubMed Web of Science ®Google Scholar
• Danne O, Möckel M, Lueders C, Mügge C, Zschunke GA, Lufft H, Müller C, Frei U. (2003). Prognostic implications of elevated whole blood choline levels in acute coronary syndromes. Am J Cardiol91:1060–7.
   PubMed Web of Science ®Google Scholar
• Dasgupta A, Chow L, Nazareno L, Tso G, Datta P. (2000). Performance evaluation of a new chemiluminescent cardiac troponin I assay. J Clin Lab Anal 14:224–9.
   PubMed Web of Science ®Google Scholar
• de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, Hall C, Cannon CP, Braunwald E. (2001). The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345:1014–21.
   PubMed Web of Science ®Google Scholar
• deFilippi CR, Parmar RJ, Potter MA, Tocchi M. (1998). Diagnostic accuracy, angiographic correlates and long-term risk stratification with the troponin T ultrasensitive rapid assay in chest pain patients at low risk for acute myocardial infarction. Eur Heart J 19 (Suppl. N):N42–7.
   Web of Science ®Google Scholar
• Dutra RF, Kubota LT. (2007). An SPR immunosensor for human cardiac troponin T using specific binding avidin to biotin at carboxymethyldextran-modified gold chip. ClinChimActa 376:114–20.
   PubMed Web of Science ®Google Scholar
• Eggers KM, Dellborg M, Johnston N, Oldgren J, Swahn E, Venge P, Lindahl B.(2010). Myeloperoxidase is not useful for the early assessment of patients with chest pain. ClinBiochem43:240–5.
   PubMed Web of Science ®Google Scholar
• Floriano PN, Christodoulides N, Miller CS, Ebersole JL, Spertus J, Rose BG, Kinane DF, Novak MJ, Steinhubl S, Acosta Sand others. (2009). Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. ClinChem 55:1530–8.
   Google Scholar
• Gerhardt W, Waldenstr J, Billstr R, Hofvendahl S. (1979). Creatine kinase B-subunit activity in serum: three years’ experience with M-subunit immunoinhibitors and routine application to the diagnosis of acute myocardial infarction (AMI). ClinBiochem 12:211–13.
   PubMedGoogle Scholar
• Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. (2010). Analytical Validation of a high-sensitivity cardiac troponin T assay. ClinChem: 56:254–61.
   Google Scholar
• Gibler WB, Gary PY, Jerris RH, Larry ML, Mark SS, Steve CC, Richard VA, Robert OJ, Allison EJ, Edward JOand others. (1992). Acute myocardial infarction in chest pain patients with nondiagnostic ECGs: serial CK-MB sampling in the emergency department. Ann Emerg Med 21:504–12.
   PubMed Web of Science ®Google Scholar
• Gornall DA, Levinoff Roth SN. (1996). Serial myoglobin quantitation in the early assessment of myocardial damage: a clinical study. ClinBiochem29:379–84.
   PubMed Web of Science ®Google Scholar
• Gorski J, Hermens WT, Borawski J, Mysliwiec M, Glatz JFC. (1997). Increased fatty acid-binding protein concentration in plasma of patients with chronic renal failure. ClinChem 43:193a–5.
   Google Scholar
• Harry PS, Robert JZ, Elliott MA, Tom PA, Sheilah Ann B, Robert OB, Gibler WB, Michael DH, Paula J, Joseph L and others.(1997). Creatine kinase. Ann Emerg Med 29:59–63.
   Google Scholar
• Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML, the CSI.(2003). Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348:1104–11.
   PubMed Web of Science ®Google Scholar
• Hong B, Tang L, Ren Y, Kang KA. (2007). Real-time, automated, fluorophore mediated multi-cardiac marker biosensing system with nano-metallic particle reagent. AdvExp Med Biol599:23–9.
   Web of Science ®Google Scholar
• Howie-Esquivel J, White M. (2008). Biomarkers in acute cardiovascular disease. J CardiovascNurs 23:124–31.
   Google Scholar
• Ilva T, Lund J, Porela P, Mustonen H, Voipio-Pulkki LM, Eriksson S, Pettersson K, Tanner P, Pulkki K. (2009). Early markers of myocardial injury: cTnI is enough. ClinChimActa 400:82–5.
   PubMed Web of Science ®Google Scholar
• Inbar R, Shoenfeld Y. (2009). Elevated cardiac troponins: the ultimate marker for myocardial necrosis, but not without a differential diagnosis. Isr Med Assoc J 11:50–3.
   PubMed Web of Science ®Google Scholar
• Jaffe AS. (2001). New standard for the diagnosis of acute myocardial infarction. Cardiol Rev 9:318–22.
   PubMedGoogle Scholar
• Jernberg T, James S, Lindahl B, Stridsberg M, Venge P, Wallentin L. (2004). NT-proBNP in unstable coronary artery disease – experiences from the FAST, GUSTO IV and FRISC II trials. Eur J Heart Fail 6:319–25.
   PubMed Web of Science ®Google Scholar
• Jernberg T, Stridsberg M, Venge P, Lindahl B. (2002). N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am CollCardiol40:437–45.
   Web of Science ®Google Scholar
• Karras DJ, Kane DL. (2001). Serum markers in the emergency department diagnosis of acute myocardial infarction. Emerg Med Clin North Am 19:321–37.
   PubMed Web of Science ®Google Scholar
• Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, Bickel C, Baldus S, Warnholtz A, Frohlich M and others. (2009). Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 361:868–77.
   PubMed Web of Science ®Google Scholar
• Khan SQ, Dhillon O, Struck J, Quinn P, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL. (2007a). C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study. Am Heart J 154:736–42.
   PubMed Web of Science ®Google Scholar
• Khan SQ, Dhillon OS, O’Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL. (2007b). C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 115:2103–10.
   PubMed Web of Science ®Google Scholar
• Kim Y, Kim H, Kim SY, Lee HK, Kwon HJ, Kim YG, Lee J, Kim HM, So BH. (2010). Automated heart-type fatty acid-binding protein assay for the early diagnosis of acute myocardial infarction. Am J ClinPathol134:157–62.
   Web of Science ®Google Scholar
• Kost GJ, Tran NK. (2005). Point-of-care testing and cardiac biomarkers: the standard of care and vision for chest pain centers. CardiolClin 23:467–90, vi.
   Web of Science ®Google Scholar
• Lewandrowski K, Chen A, Januzzi J. (2002). Cardiac markers for myocardial infarction.A brief review. Am J ClinPathol 118 (Suppl.):S93–9.
   Google Scholar
• Mair J. (1997a). Cardiac troponin I and troponin T: are enzymes still relevant as cardiac markers? ClinChimActa 257:99–115.
   PubMed Web of Science ®Google Scholar
• Mair J. (1997b). Progress in myocardial damage detection: new biochemical markers for clinicians. Crit Rev Clin Lab Sci34:1–66.
   PubMed Web of Science ®Google Scholar
• Mair J. (1998). Glycogen phosphorylase isoenzyme BB to diagnose ischaemic myocardial damage. ClinChimActa 272:79–86.
   PubMed Web of Science ®Google Scholar
• Mair J, Morandell D, Genser N, Lechleitner P, Dienstl F, Puschendorf B. (1995). Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. ClinChem41:1266–72.
   Google Scholar
• Majeed R, Jaleel A, Siddiqui IA, Sandila P, Baseer A. (2002). Comparison of troponin T and enzyme levels in acute myocardial infarction and skeletal muscle injury. J Ayub Med Coll Abbottabad 14:5–7.
   PubMedGoogle Scholar
• Malasky BR, Alpert JS. (2002). Diagnosis of myocardial injury by biochemical markers: problems and promises. Cardiol Rev 10:306–17.
   PubMedGoogle Scholar
• McCann CJ, Glover BM, Menown IBA, Moore MJ, McEneny J, Owens CG, Smith B, Sharpe PC, Young IS, Adgey JA. (2008a). Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J 29:2843–50.
   PubMed Web of Science ®Google Scholar
• McCord J, Nowak RM, McCullough PA, Foreback C, Borzak S, Tokarski G, Tomlanovich MC, Jacobsen G, Weaver WD. (2001). Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation 104:1483–8.
   PubMed Web of Science ®Google Scholar
• McDonnell B, Hearty S, Leonard P, O’Kennedy R. (2009). Cardiac biomarkers and the case for point-of-care testing. ClinBiochem 42:549–61.
   PubMed Web of Science ®Google Scholar
• Mion MM, Novello E, Altinier S, Rocco S, Zaninotto M, Plebani M. (2007). Analytical and clinical performance of a fully automated cardiac multi-markers strategy based on protein biochip microarray technology. ClinBiochem40:1245–51.
   PubMed Web of Science ®Google Scholar
• Mocatta TJ, Pilbrow AP, Cameron VA, Senthilmohan R, Frampton CM, Richards AM, Winterbourn CC. (2007). Plasma Concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am CollCardiol 49:1993–2000.
   Google Scholar
• Morrow DA.(2007). Appraisal of myeloperoxidase for evaluation of patients with suspected acute coronary syndromes. J Am CollCardiol 49(20):(2001)–(2002).
   Web of Science ®Google Scholar
• Muller-Bardorff M, Freitag H, Scheffold T, Remppis A, Kubler W, Katus HA. (1995). Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. Circulation 92:2869–75.
   PubMed Web of Science ®Google Scholar
• Nadeau L, Baril P, Turcotte G, Michel C. (1997). Myoglobin (MYO) and cardiac troponin I (CTNI) in diagnosis of suspected acute myocardial infarct (AMI). ClinBiochem30:369–70.
   Google Scholar
• Nageh T, Sherwood RA, Harris BM, Byrne JA, Thomas MR. (2003). Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention. Int J Cardiol92:285–93.
   PubMed Web of Science ®Google Scholar
• Navarro Estrada JL, Rubinstein F, Bahit MC, Rolandi F, Perez de Arenaza D, Gabay JM, Alvarez J, Sarmiento R, Rojas Matas C, Sztejfman C, Tettamanzi A, de Miguel R, Guzman L; PACS Investigators.(2006). NT-probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non-ST-elevation acute coronary syndromes. Am Heart J 151:1093.e1-e7.
   PubMed Web of Science ®Google Scholar
• Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C and others. (2007). Prognostic value of B-type natriuretic peptides in patients with stable coronary artery disease: the PEACEtTrial. J Am CollCardiol50:205–14.
   Web of Science ®Google Scholar
• Panteghini M, Pagani F. (1996). Characterization of a rapid immunochromatographic assay for simultaneous detection of high concentrations of myoglobin and CK-MB in whole blood. ClinChem 42:1292–3.
   Google Scholar
• Park JP, Cropek DM, Banta S. (2010). High affinity peptides for the recognition of the heart disease biomarker troponin I identified using phage display. BiotechnolBioeng 105:678–86.
   Google Scholar
• Peetz D, Post F, Schinzel H, Schweigert R, Schollmayer C, Steinbach K, Dati F, Noll F, Lackner KJ. (2005). Glycogen phosphorylase BB in acute coronary syndromes. ClinChem Lab Med 43:1351–8.
   Google Scholar
• Peivandi AA, Dahm M, Hake U, Hafner G, Opfermann UT, Loos AH, Tzanova I, Oelert H. (2001).Patterns and diagnostic value of cardiac troponin I vs. troponin T and CKMB after OPCAB surgery. ThoracCardiovascSurg 49:137–43.
   Google Scholar
• Pelsers MM, Hermens WT, Glatz JF. (2005). Fatty acid-binding proteins as plasma markers of tissue injury. ClinChimActa 352:15–35.
   PubMed Web of Science ®Google Scholar
• Penttila K, Koukkunen H, Halinen M, Rantanen T, Py K, Punnonen K, Penttil I. (2002). Myoglobin, creatine kinase MB isoforms and creatine kinase MB mass in early diagnosis of myocardial infarction in patients with acute chest pain. ClinBiochem 35:647–53.
   PubMed Web of Science ®Google Scholar
• Penttila K, Koukkunen H, Kemppainen A, Halinen M, Rantanen T, Pyorala K, Penttila I. (1999). Myoglobin, creatine kinase MB, troponin T, and troponin I - rapid bedside assays in patients with acute chest pain. Int J Clin Lab Res 29:93–101.
   PubMedGoogle Scholar
• Peter AK, Andrew RM, Viliam L, Rakesh B, Rudy V, Glenn EP, Marie-Jeanne Y, Allan SJ. (2006). The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. Am Heart J 152:118–25.
   PubMedGoogle Scholar
• Plebani M, Zaninotto M. (1999). Cardiac markers: present and future. Int J Clin Lab Res 29:56–63.
   PubMedGoogle Scholar
• Rabitzsch G, Mair J, Lechleitner P, Noll F, Hofmann U, Krause EG, Dienstl F, Puschendorf B. (1995). Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. ClinChem41:966–78.
   Google Scholar
• Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M and others. (2009). Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 361:858–67.
   PubMed Web of Science ®Google Scholar
• Reis GJ, Kaufman HW, Horowitz GL, Pasternak RC.(1988). Usefulness of lactate dehydrogenase and lactate dehydrogenase isoenzymes for diagnosis of acute myocardial infarction. Am J Cardiol 61:754–8.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E. (2005). C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352:20–8.
   PubMed Web of Science ®Google Scholar
• Schonbeck U, Varo N, Libby P, Buring J, Ridker PM. (2001). Soluble CD40L and cardiovascular risk in women. Circulation 104:2266–8.
   PubMed Web of Science ®Google Scholar
• Scirica BM, Morrow DA. (2004). Troponins in acute coronary syndromes. ProgCardiovasc Dis 47:177–88.
   Google Scholar
• Senter S, Francis GS.(2009). A new, precise definition of acute myocardial infarction. Cleve Clin J Med 76:159–66.
   PubMed Web of Science ®Google Scholar
• Shimpo M, Morrow DA, Weinberg EO, Sabatine MS, Murphy SA, Antman EM, Lee RT. (2004). Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation109:2186–90.
   PubMed Web of Science ®Google Scholar
• Shishehbor MH, Bhatt DL, Topol EJ. (2003). Using C-reactive protein to assess cardiovascular disease risk. Cleve Clin J Med 70:634–40.
   PubMed Web of Science ®Google Scholar
• Simon C, Capuano F, Roscitano A, Benedetto U, Comito C, Sinatra R. (2008). Cardiac troponin I vs EuroSCORE: myocardial infarction and hospital mortality. Asian CardiovascThorac Ann 16:97–102.
   PubMedGoogle Scholar
• Tanaka T, Hirota Y, Sohmiya K-I Nishimura, S, Kawamura K. (1991). Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. ClinBiochem 24:195–201.
   PubMed Web of Science ®Google Scholar
• Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng Z-J Flegal, K, O’Donnell C, Kittner Sand others. (2006). Heart Disease and Stroke Statistics – 2006 Update: a Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113:e85–151.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B. (2007a). Universal definition of myocardial infarction. Eur Heart J 28:2525–38.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, White HD. (2007b). Universal definition of myocardial infarction. Circulation 116:2634–53.
   PubMed Web of Science ®Google Scholar
• Uettwiller-Geiger D, Wu AHB, Apple FS, Jevans AW, Venge P, Olson MD, Darte C, Woodrum DL, Roberts S, Chan S. (2002). Multicenter evaluation of an automated assay for troponin I. ClinChem 48:869–76.
   Google Scholar
• Vasan RS.(2006). Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 113:2335–62.
   PubMed Web of Science ®Google Scholar
• Wallace KB, Hausner E, Herman E, Holt GD, Macgregor JT, Metz AL, Murphy E, Rosenblum IY, Sistare FD, York MJ. (2004). Serum troponins as biomarkers of drug-induced cardiac toxicity. ToxicolPathol32:106–21.
   Web of Science ®Google Scholar
• Wang J, Hong B, Kai J, Han J, Zou Z, Ahn CH, Kang KA. (2009). Mini sensing chip for point-of-care acute myocardial infarction diagnosis utilizing micro-electro-mechanical system and nano-technology. AdvExp Med Biol645:101–7.
   Web of Science ®Google Scholar
• Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ and others. (2006). Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355:2631–9.
   PubMed Web of Science ®Google Scholar
• Weinberg EO, Shimpo M, De Keulenaer GW, MacGillivray C, Tominaga S, Solomon SD, Rouleau JL, Lee RT. (2002a). Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106:2961–6.
   PubMed Web of Science ®Google Scholar
• Worster A, Balion CM, Hill SA, Santaguida P, Ismaila A, McKelvie R, Reichert SM, McQueen MJ, Booker L, Raina PS. (2008). Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: A systematic review. ClinBiochem 41:250–9.
   PubMed Web of Science ®Google Scholar
• Wu AH.(1998). Analytical and clinical evaluation of new diagnostic tests for myocardial damage. ClinChimActa 272:11–21.
   PubMed Web of Science ®Google Scholar
• Wu AH.(1999). Cardiac markers: from enzymes to proteins, diagnosis to prognosis, laboratory to bedside. Ann Clin Lab Sci29:18–23.
   PubMed Web of Science ®Google Scholar
• Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr. (1999). National Academy of Clinical Biochemistry standards of laboratory practice: recommendations for the use of cardiac markers in coronary artery diseases. ClinChem45:1104–21.
   Google Scholar
• Yang Z, Min Zhou D. (2006).Cardiac markers and their point-of-care testing for diagnosis of acute myocardial infarction. ClinBiochem39:771–80.
   PubMed Web of Science ®Google Scholar
• Yu H, Rifai N. (2000). High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy. ClinBiochem 33:601–10.
   PubMed Web of Science ®Google Scholar
• Yue B, Pattison E, Roberts WL, Rockwood AL, Danne O, Lueders C, Mockel M. (2008). Choline in whole blood and plasma: sample preparation and stability. ClinChem54:590–3.
   Google Scholar
• Zehra J, Richard N, Nabil K, Glen T, David EL, Gordon J, James M. (2008). Myoglobin and troponin I elevation predict 5-year mortality in patients with undifferentiated chest pain in the emergency department. Am Heart J 156:939–45.
   PubMed Web of Science ®Google Scholar
• Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlov J. (2008). Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.N Engl J Med 358:2107–16.
   PubMed Web of Science ®Google Scholar
• Zhang R, Brennan M-L Shen, Z, MacPherson JC, Schmitt D, Molenda CE, Hazen SL. (2002). Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J BiolChem 277:46116–22.
   PubMed Web of Science ®Google Scholar